Back to Home Page
Professor Ariane
DeAgostini, University of Geneva Medical School, Geneva,
Switzerland - Folicular fluid glycosaminogylcans.

Professor Jon
Amster, University of
Georgia, Athens, GA —
FT-ICR MS for the determination of glycosaminoglycan structure.

Professor Jesus
Jimenez Barbero, Istituto
de Quìmica Orgánica, CSIC, Madrid, Spain — Conformation of
Neuraminic Acid C-glycosides.

Professor
Thomas
Baumert and Michael
Nassal University of Frieburg, Germany —
Hepatitis C and Glycosaminoglycans

<>
Professor Mirek Cygler,
Biotechnology Research Institute, Montreal, Canada — Xray
Cocrystallization
of Polysaccharide Lyases with Oligosaccharides.

Professor Paul
DeAngelis,
University
of Oklahoma Health Sciences Center, Oklahoma City, OK — Microbial
Enzymes in the Synthesis of Glycosaminoglycans.

Professor Jonathan
Dordick, Rensselaer
Polytechnic Institute, Troy, NY —
Enzymes in RTILs and on nano
structures.

Professor Jawed Fareed,
Loyola
University,
Illinois — Anticoagulant Activity and
Bioavailablity of Heparinoids.

Professor Hari Garg, Harvard Medical
School, Massachusetts — Glycosaminoglycans and
Angiogenesis.

Professor Linda Hiebert, University
of Saskatchewan, Saskatoon, Canada — Oral Bioavailability of Heparin.

Professor
Dena Howland, University of Florida,
Gainsville, FL - Chondroitinase for the treatment of spinal cord injury.

Professor
Dennis Kasper, Harvard
University Medical School, Boston, MA — MHCII
pathway and the
generation of IgG antibodies against heparin and related
polysaccharides.

Professor
Patrick Page-McCaw, RPI Department of Biology -
Angiogenesis and vasculargensis in zebrafish.

Professor
Yeong-Shik
Kim, Seoul
National
University, South Korea — Isolation of GAGs Having Novel
Structures.
Professor Jian
Liu, University of North Carolina, Chapel Hill, NC — Biosynthetic
Enzymes and Glycosaminoglycans.

Professor
Shaker Mousa, Albany College of
Pharmacy, Albany, NY — Heparin and
Thromosis and Hemostasis and Angiogenesis.

Professor Miriam Barrow,
Harvard University Medical School - Interaction of ACP bacterial
protein with heparin/HS.

Professor
Scott McCallum, Biotechnology
Center, RPI, Troy, NY - VEGF - Synthetic heparin interactions.

Professor
Moosa
Mohammadi, NYU, New
York — FGF-FGFR-Heparin Interactions.
Professor
Michael Pierce, CCRC,
University of Georgia, Athens, GA — Glycomics of heparan sulfate in
stem cell differenliation.

Professor Kelley Moremen, Alison Nairn, and Steve
Dalton, CCRC
and University of Georgia, Athens, GA - Glycomics of heparan sulfate in
stem cell

Professor Susan Sharfstein, Rensselaer
Polytechnic Institute, Troy, NY —
Engineering of Glycans.

Professor Photini
Sinnis, NYU, NYC, NY — Role of heparan sulfate in
malaria.

Professor Toshihiko
Toida, Chiba
University,
Japan — Preparation and analysis of
oligosaccharides.

Professor Jeremy Turnbull, University
of
Birmingham, U.K. — Sequencing Heparin Oligosaccharides.

Professor Brian
Volkman, Medical College of Wisconsin, Milwaukee — NMR of
Heparin Interaction
with Lymphotactin and PSP-1.

Dr. Joanne K. Tobacman,
University of Illinois, Chicago — Carrageenan related physiology.

Professor Preeyanat Vongchan, Chiang
Mai University, Thailand - HSPG related antibodies and immunology.

Professor Steven R. Van Doren, University
of Missouri, Columbia - GAG-protein (pro-matrilysin, MMP-7) interactions.

Professor Pulickel
Ajayan, Rice
University —
Nanoscience.

Professor George
Drusano, Ordway,
Albany — Anti-influenza agents.

Back to Home Page